HC Surgical Specialists (1B1) Stock Overview

HC Surgical Specialists Limited, an investment holding company, provides medical services primarily in Singapore. The company provides endoscopic procedures, including gastroscopies and colonoscopies; and general surgery services with a focus on colorectal procedures in a network of clinics. It also offers treatment services for other conditions, such as haemorrhoids, anal abscesses, anal fissures, anal fistula, gallstones and inflammation of the gallbladder, appendicitis, hernias, gastric and colorectal cancer, colonic diverticular disease, and cysts and lipomas; vein laser vascular, laparoscopy, cholecystitis, and other general and specialized medical services; and orthopedic services comprising joint pain, sports injuries, osteoarthritis, rotator cuff tears, trigger finger, carpel tunnel syndrome, wounds/lumps, joint replacement, arthroscopic surgery, and fractures. In addition, the company provides home care services, which include medical, nursing, physiotherapy, speech therapy, occupational therapy, and ambulance services; health screening, management of acute and chronic conditions, and pre-employment check-up; public health preparedness clinic scheme, swab and send home program, community health assist scheme, and COVID-19 swab test services; and a range of diagnostic tests that comprise blood tests, X-Rays, ultrasound, CT scans, and MRIs. HC Surgical Specialists Limited was incorporated in 2015 and is based in Singapore.